COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM LONG; STENT, SUPERFICIAL FEMORAL ARTERY
|
Back to Search Results |
|
Model Number EVD35-07-150-120 |
Device Problems
Deformation Due to Compressive Stress (2889); Activation, Positioning or Separation Problem (2906); Detachment of Device or Device Component (2907)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/26/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Physician used an everflex entrust self-expanding stent with a non-medtronic (terumo slender) sheath and a 0.035 guidewire during treatment of a 150mm plaque lesion in the patient¿s left proximal mid distal superficial femoral artery (sfa), popliteal artery, tibial/popliteal trunk & anterior tibial artery.Artery diameter is reported as 4-7mm.Little vessel calcification and no vessel tortuosity are reported.Lesion exhibited 0-15% stenosis.No embolic protection was used.There was no damage noted to packaging, i.E.Shelf carton, hoop/tray.No issues were noted when removing the device from the hoop/tray.Ifu was followed and the device was prepped without issue.Pre-dilation was performed using a 5x120 evercross dilatation catheter.The stent was did pass through a previously deployed stent.No resistance was encountered when advancing the device.No excessive force was used.This case was pedal access.Upon the first approximate 30 mm of the stent¿s deployment the toggle wheel ¿snapped/broke¿ and the wheel spun freely.Manual deployment of the stent was initiated and the stent was deployed in the vessel bed(s).Upon initiation of manual deployment it was noticed that the toggle wheel line was severed and there was a kink in the distal silver shaft and the proximal aspect of the blue sheath.The procedure was completed with no injury or known or adverse reaction to the patient.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Additional information: the stent was originally deployed in the target location.The stent system was safely removed.There is no known or appreciable vessel damage or harm to the patient.Image analysis: the customer returned two images.Image 1 shows the deployment wheel, pulley, pullwire and section of shaft of an everflex entrust device.The pullwire is broken off the shaft.All the components have been removed from the device handle and the handle is not in the image.Image 2 the shaft distal to the strain relief.There is a kink on the shaft.Product analysis: the stent was not returned.The handle was returned in two parts, the deployment wheel and pull wire were detached from the silver retractable isolation sheath.The device was returned with two kinks observed to the gold isolation sheath, a kink was observed on the gold isolation sheath at approx.15cm when measured from the distal end of the device and at approx.28.3cm from the distal end of the device.No functional testing could be carried out due to the condition of the returned device.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|